Heterogeneity of cell therapy products
S. Afr. med. j. (Online)
;
109(8): 25-29, 2019. ilus
Artigo
em Inglês
| AIM
| ID: biblio-1271225
ABSTRACT
Cellular therapy has become a billion-dollar industry and is set to become one of the therapeutic pillars of healthcare in the 21st century. Adult stem cells, which include haematopoietic stem and progenitor cells (HSPCs) and mesenchymal stromal/stem cells (MSCs), is one of the major cell types currently under investigation for use in cell therapy. This review focuses on HSPCs and MSCs and discusses their heterogeneous nature and the problems faced in expanding these cells to therapeutic numbers for use in clinical applications
Buscar no Google
Índice:
AIM (África)
Assunto principal:
Terapêutica
/
Produtos do Gene gag
/
Células
/
Heterogeneidade Genética
Idioma:
Inglês
Revista:
S. Afr. med. j. (Online)
Ano de publicação:
2019
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS